Skip to main content
Cardiolucent

Condition

History of heart attack (myocardial infarction)

Symptoms & Risk Factors

Surviving a heart attack changes the rules of cardiovascular care. The risk of a second event remains meaningfully elevated for years, but it can be substantially reduced — often by more than half — with disciplined post-MI management. After the initial stent, bypass, or medical stabilization, the long-term work is in optimizing guideline-directed medical therapy, recovering function safely through cardiac rehabilitation, and pursuing aggressive secondary prevention across lipids, blood pressure, glucose, weight, and tobacco. Many recurrent events trace back to medication discontinuation, suboptimal dosing, or missed risk-factor goals rather than to anything new in the coronary anatomy itself. Dr. Kedan structures post-MI care as a long-term partnership, with frequent enough touchpoints to keep the regimen tuned and the patient supported.

What Cardiolucent Evaluates

  • Detailed review of the index event, anatomy, procedures performed, and discharge medications
  • Guideline-directed medical therapy optimization including statin intensity, antiplatelets, beta-blocker, and ACE/ARB/ARNI
  • Dual antiplatelet therapy duration planning matched to stent type and bleeding risk
  • Serial echocardiography and POCUS to track recovery of left ventricular function
  • Advanced lipid panel with ApoB and lipoprotein(a), with treat-to-target follow-up
  • Comprehensive risk-factor management including blood pressure, glucose, weight, sleep, and tobacco
  • Cardiac rehabilitation coordination and exercise prescription
  • Coordination with interventional cardiology at Cedars-Sinai for surveillance imaging or repeat intervention

Recurrence Warning Symptoms

  • Recurrent chest pressure, tightness, or burning similar to the original heart attack
  • Shortness of breath that is new, worsening, or out of proportion to activity
  • Reduced exercise tolerance or unusual fatigue
  • Palpitations or new irregular heartbeat
  • Leg swelling, weight gain, or difficulty lying flat (signs of heart failure)
  • Lightheadedness, near-fainting, or fainting
  • Any of the above acutely — especially chest pain with sweating, nausea, or arm/jaw radiation — is a 911 emergency, not a clinic visit

Risk Factors for Recurrence

  • Premature discontinuation of statin, antiplatelet, or beta-blocker therapy
  • Suboptimal LDL or ApoB control
  • Persistent tobacco use after the index event
  • Uncontrolled hypertension or diabetes
  • Untreated obstructive sleep apnea
  • Sedentary lifestyle and failure to complete cardiac rehabilitation
  • Persistent obesity, particularly visceral adiposity
  • Multi-vessel coronary disease at the time of the index event
  • Reduced left ventricular function after the event
  • Untreated depression and chronic psychosocial stress

How Cardiolucent Approaches Treatment

Dr. Kedan personally oversees the long arc of post-MI care, treating it as a single coordinated project rather than a series of disconnected visits. The early phase focuses on guideline-directed medical therapy at the right doses, dual antiplatelet duration matched to your specific stent and bleeding risk, structured cardiac rehabilitation, and recovery of exercise capacity. The maintenance phase keeps lipids, blood pressure, glucose, and weight at protective targets indefinitely. The concierge model is well suited to this work — between-visit access lets Dr. Kedan adjust medications quickly, evaluate new symptoms without delay, and prevent the medication slippage that drives most second events.

Common Questions

Frequently Asked Questions

What care do I need after a heart attack?
After a heart attack, the priorities are preventing a second event, supporting recovery of heart function, and rebuilding capacity safely. That involves optimizing guideline-directed medications, managing risk factors aggressively, completing cardiac rehabilitation, and tracking heart function over time. Dr. Kedan structures post-MI care as a long-term partnership rather than a series of isolated visits.
What is the risk of having another heart attack?
Recurrence risk is meaningful in the first year and remains elevated long term, but it can be reduced substantially with the right regimen. Most second events are driven by uncontrolled risk factors or premature discontinuation of medication, which is why follow-up matters so much. With consistent care, many patients live decades after their first MI in good cardiovascular health.
How long do I need to stay on blood thinners after a stent?
Dual antiplatelet therapy — typically aspirin plus a second agent — is generally continued for 6–12 months after stent placement, with longer or shorter durations depending on the type of stent, bleeding risk, and overall cardiovascular profile. After that period, most patients continue on a single antiplatelet medication indefinitely. Dr. Kedan reviews the timing carefully and adjusts based on your specific situation rather than applying a fixed rule.
How is recovery monitored?
Recovery monitoring includes serial echocardiography to track how the heart muscle is healing, regular medication review, biomarker follow-up, and ongoing assessment of exercise capacity. POCUS during office visits allows Dr. Kedan to reassess function as part of routine care. Any new chest discomfort, shortness of breath, or fatigue is taken seriously and evaluated promptly.
Is cardiac rehabilitation worth it?
Cardiac rehabilitation is one of the most underused interventions in cardiology, and it consistently improves outcomes, exercise capacity, and quality of life after a heart attack. A structured supervised program teaches you how to exercise safely, addresses risk factors, and builds confidence. Dr. Kedan strongly recommends it and helps coordinate enrollment when appropriate.
When can I exercise again, and how hard?
Most patients begin gentle activity within days of leaving the hospital, with a graded return to more vigorous exercise over the following weeks. The right intensity depends on the size of the heart attack, recovery of function, and any procedures performed. Dr. Kedan provides a personalized activity plan and recalibrates it as your strength and confidence return.
What lifestyle changes matter most after an MI?
Smoking cessation, a Mediterranean-style diet, regular aerobic and resistance exercise, weight optimization, treatment of sleep apnea, and stress management all have substantial evidence supporting them. Strict adherence to your medication regimen — particularly statin and antiplatelet therapy — is equally important. These steps are not optional add-ons; they are the foundation of long-term protection.
What symptoms should make me seek emergency care?
Chest pain or pressure that feels similar to your previous heart attack, especially with shortness of breath, sweating, nausea, jaw or arm radiation, or fainting, should prompt an immediate 911 call. Don't try to drive yourself or wait it out. For non-emergent changes such as gradual decreases in exercise tolerance or new mild symptoms, call Cardiolucent at (310) 304-5555 so Dr. Kedan can assess promptly.
How often will I see the cardiologist long term?
In the first year after a heart attack, visits are typically every 2–3 months as medications are optimized and recovery progresses. Once stable, visits move to every 3–6 months. The concierge model means you can reach Dr. Kedan directly between visits, which often prevents small concerns from becoming larger ones.

Ready to learn more about History of heart attack (myocardial infarction)?

Schedule a private consultation with Dr. Kedan in Beverly Hills.

Medical Disclaimer

The information on this site is for general educational purposes only and is not medical advice, diagnosis, or treatment. Reading this site does not create a doctor–patient relationship. Always consult a qualified healthcare professional for personal guidance. If this is an emergency, call 911. Mentions of medications, devices, or procedures are informational and not endorsements. Full medical disclaimer.

Some listed indications involve investigational/off-label use. Learn more.